Compounds > chlormadinone acetate
Page last updated: 2024-08-21

chlormadinone acetate and Substance Withdrawal Syndrome

chlormadinone acetate has been researched along with Substance Withdrawal Syndrome in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujikawa, N; Murai, T; Noguchi, K; Saito, K; Teranishi, J; Uemura, H1
Akakura, K; Akimoto, S; Ohki, T; Shimazaki, J1
Aida, S; Akakura, K; Akimoto, S; Komiya, A; Shimazaki, J; Suzuki, H1
Akakura, K; Akimoto, S; Furuya, Y; Ito, H1

Other Studies

4 other study(ies) available for chlormadinone acetate and Substance Withdrawal Syndrome

ArticleYear
Complete response, as determined by prostate-specific antigen level, to chlormadinone acetate withdrawal persisting longer than 2 years in patients with advanced prostate cancer: two case reports.
    International journal of urology : official journal of the Japanese Urological Association, 2006, Volume: 13, Issue:9

    Topics: Aged; Androgen Antagonists; Chlormadinone Acetate; Humans; Male; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome; Survival Rate

2006
Antiandrogen withdrawal syndrome in prostate cancer after treatment with steroidal antiandrogen chlormadinone acetate.
    Urology, 1995, Volume: 45, Issue:4

    Topics: Aged; Aged, 80 and over; Chlormadinone Acetate; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome

1995
Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome.
    The Prostate, 1996, Volume: 29, Issue:3

    Topics: Aged; Amino Acid Sequence; Androgen Antagonists; Chlormadinone Acetate; Codon; Genes; Genetic Variation; Humans; Male; Mutation; Orchiectomy; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Substance Withdrawal Syndrome

1996
Incidence and characteristics of antiandrogen withdrawal syndrome in prostate cancer after treatment with chlormadinone acetate.
    European urology, 1998, Volume: 33, Issue:6

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Chlormadinone Acetate; Humans; Male; Middle Aged; Neoplasm Staging; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome; Treatment Outcome

1998